| Dr Michael C Reed, MD | |
|
500 West Broadway, St. Patrick Hospital, Missoula, MT 59802-4008 | |
| (406) 543-7271 | |
| Not Available |
| Full Name | Dr Michael C Reed |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 21 Years |
| Location | 500 West Broadway, Missoula, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346396967 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 44541 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St. Patrick Hospital | Missoula, MT | Hospital |
| St Luke Community Hospital | Ronan, MT | Hospital |
| Providence St Joseph Medical Center | Polson, MT | Hospital |
| St Peters Hospital | Helena, MT | Hospital |
| St James Healthcare | Butte, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Mt | 6608786306 | 272 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has initiated a Phase 1 study of PV-10 for liver cancer. The study will enroll up to six subjects with cancer metastatic to the liver or with recurrent liver cancer. PV-10 is the company's lead oncology drug candidate that is also currently undergoing Phase 2 study for metastatic melanoma.
Two new tools that enable the public to report sick or dead wild animals could also lead to the detection and containment of wildlife disease outbreaks that may pose a health risk to people.
Stanford University Medical Center's decision to prohibit physicians from accepting any gifts from pharmaceutical sales representatives is "an austere measure that other medical centers should follow," a Los Angeles Times editorial states.
As the health care overhaul battle moves out of Washington and onto the airwaves and Main Streets during the August recess, America's Health Insurance Plans (AHIP), the trade association for the nation's health insurers, is fighting a familiar battle.
The side effects of the Pfizer-BioNTech jab against COVID-19 are likely to be mild to moderate and clear up quickly in 12-15 year olds at high risk of complications from the infection because of certain coexisting conditions, reveals a small study accepted for publication in the Archives of Disease in Childhood.
› Verified 2 days ago
| Entity Name | Providence Health & Services Mt |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144319138 PECOS PAC ID: 6608786306 Enrollment ID: O20031229000787 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has initiated a Phase 1 study of PV-10 for liver cancer. The study will enroll up to six subjects with cancer metastatic to the liver or with recurrent liver cancer. PV-10 is the company's lead oncology drug candidate that is also currently undergoing Phase 2 study for metastatic melanoma.
Two new tools that enable the public to report sick or dead wild animals could also lead to the detection and containment of wildlife disease outbreaks that may pose a health risk to people.
Stanford University Medical Center's decision to prohibit physicians from accepting any gifts from pharmaceutical sales representatives is "an austere measure that other medical centers should follow," a Los Angeles Times editorial states.
As the health care overhaul battle moves out of Washington and onto the airwaves and Main Streets during the August recess, America's Health Insurance Plans (AHIP), the trade association for the nation's health insurers, is fighting a familiar battle.
The side effects of the Pfizer-BioNTech jab against COVID-19 are likely to be mild to moderate and clear up quickly in 12-15 year olds at high risk of complications from the infection because of certain coexisting conditions, reveals a small study accepted for publication in the Archives of Disease in Childhood.
› Verified 2 days ago
| Entity Name | Providence St Joseph Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669655528 PECOS PAC ID: 0446230247 Enrollment ID: O20040910001134 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has initiated a Phase 1 study of PV-10 for liver cancer. The study will enroll up to six subjects with cancer metastatic to the liver or with recurrent liver cancer. PV-10 is the company's lead oncology drug candidate that is also currently undergoing Phase 2 study for metastatic melanoma.
Two new tools that enable the public to report sick or dead wild animals could also lead to the detection and containment of wildlife disease outbreaks that may pose a health risk to people.
Stanford University Medical Center's decision to prohibit physicians from accepting any gifts from pharmaceutical sales representatives is "an austere measure that other medical centers should follow," a Los Angeles Times editorial states.
As the health care overhaul battle moves out of Washington and onto the airwaves and Main Streets during the August recess, America's Health Insurance Plans (AHIP), the trade association for the nation's health insurers, is fighting a familiar battle.
The side effects of the Pfizer-BioNTech jab against COVID-19 are likely to be mild to moderate and clear up quickly in 12-15 year olds at high risk of complications from the infection because of certain coexisting conditions, reveals a small study accepted for publication in the Archives of Disease in Childhood.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael C Reed, MD 500 W Broadway St, Providence Saint Patrick Hospital Suite 320, Missoula, MT 59802-4008 Ph: (406) 543-7271 | Dr Michael C Reed, MD 500 West Broadway, St. Patrick Hospital, Missoula, MT 59802-4008 Ph: (406) 543-7271 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has initiated a Phase 1 study of PV-10 for liver cancer. The study will enroll up to six subjects with cancer metastatic to the liver or with recurrent liver cancer. PV-10 is the company's lead oncology drug candidate that is also currently undergoing Phase 2 study for metastatic melanoma.
Two new tools that enable the public to report sick or dead wild animals could also lead to the detection and containment of wildlife disease outbreaks that may pose a health risk to people.
Stanford University Medical Center's decision to prohibit physicians from accepting any gifts from pharmaceutical sales representatives is "an austere measure that other medical centers should follow," a Los Angeles Times editorial states.
As the health care overhaul battle moves out of Washington and onto the airwaves and Main Streets during the August recess, America's Health Insurance Plans (AHIP), the trade association for the nation's health insurers, is fighting a familiar battle.
The side effects of the Pfizer-BioNTech jab against COVID-19 are likely to be mild to moderate and clear up quickly in 12-15 year olds at high risk of complications from the infection because of certain coexisting conditions, reveals a small study accepted for publication in the Archives of Disease in Childhood.
› Verified 2 days ago
Mr. George Bandow, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2809 Great Northern Loop, Suite 200, Missoula, MT 59808 Phone: 406-541-7139 Fax: 406-541-7143 | |
Simone Musco, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 500 W Broadway St, Ste 320, Missoula, MT 59802 Phone: 406-329-5615 | |
Rolf H O Holle, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1782 Elison Ln Unit 3, Missoula, MT 59802 Phone: 406-544-1871 | |
John David Anthony Lakatua, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 500 West Broadway, Missoula, MT 59802 Phone: 406-721-5600 Fax: 406-721-3907 | |
Mr. Curtis G Wickre, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 500 W Broadway St, 4th Floor, Missoula, MT 59802 Phone: 406-327-1900 | |
Dr. Charlotte Nelson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 500 W Broadway St, Missoula, MT 59802 Phone: 406-327-1613 | |
Michele A Danicich, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 900 N Orange St Ste 304, Missoula, MT 59802 Phone: 406-329-5781 Fax: 406-327-3331 |